Which of the following antihypeensive drug is avoided in patients with high serum uric acid levels?
**Core Concept:** High serum uric acid levels can lead to the development of gout and urate nephropathy, both of which can have severe complications. Antihypertensive drugs should be chosen carefully in patients with high uric acid levels to prevent exacerbating these conditions.
**Why the Correct Answer is Right:** Nitrates are contraindicated in patients with high serum uric acid levels due to their potential to cause gout flares and worsening of urate nephropathy. Gout flares are caused by the increase in urate levels and inflammation, which can be exacerbated by nitrates. In addition, nitrates can impair renal function, leading to worsening of urate nephropathy.
**Why Each Wrong Option is Incorrect:**
A. ACE inhibitors (e.g., captopril) are incorrect because they do not significantly affect uric acid levels. They primarily work by reducing angiotensin II levels and thus reducing blood pressure.
B. Calcium channel blockers (e.g., amlodipine) are incorrect because they do not cause worsening of uric acid levels or gout flares. They work by blocking calcium channels in cardiac and smooth muscle cells, leading to vasodilation and reduced blood pressure.
C. Diuretics (e.g., furosemide) are incorrect because they do not significantly affect uric acid levels. They primarily work by increasing urine output, leading to volume expansion and reduced blood pressure.
D. Angiotensin II receptor blockers (e.g., losartan) are incorrect because they do not cause worsening of uric acid levels or gout flares. They work by blocking angiotensin II receptors, leading to reduced blood pressure and vasodilation.
**Clinical Pearl:** When treating patients with hypertension, it is essential to be aware of the potential complications associated with various antihypertensive medications. Choosing appropriate medications based on patient-specific factors, such as uric acid levels, can help prevent adverse events and improve patient outcomes.